296 related articles for article (PubMed ID: 18046294)
21. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
Siddiqui U; Bini EJ; Chandarana K; Leong J; Ramsetty S; Schiliro D; Poles M
J Clin Gastroenterol; 2007; 41(5):484-90. PubMed ID: 17450031
[TBL] [Abstract][Full Text] [Related]
22. Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.
Kotb R; Vincent I; Dulioust A; Peretti D; Taburet AM; Delfraissy JF; Goujard C
Eur J Haematol; 2006 Mar; 76(3):269-71. PubMed ID: 16451402
[TBL] [Abstract][Full Text] [Related]
23. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
24. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.
Hung CC; Chang SC
J Antimicrob Chemother; 2004 Nov; 54(5):849-53. PubMed ID: 15456733
[TBL] [Abstract][Full Text] [Related]
25. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
Celentano DD; Lucas G
Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
[TBL] [Abstract][Full Text] [Related]
26. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
27. Antiretroviral medication errors among hospitalized patients with HIV infection.
Rastegar DA; Knight AM; Monolakis JS
Clin Infect Dis; 2006 Oct; 43(7):933-8. PubMed ID: 16941379
[TBL] [Abstract][Full Text] [Related]
28. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
29. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
Burgoyne RW; Tan DH
J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
[TBL] [Abstract][Full Text] [Related]
30. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
[TBL] [Abstract][Full Text] [Related]
31. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
[TBL] [Abstract][Full Text] [Related]
32. Impact of depression on HIV outcomes in the HAART era.
Hartzell JD; Janke IE; Weintrob AC
J Antimicrob Chemother; 2008 Aug; 62(2):246-55. PubMed ID: 18456650
[TBL] [Abstract][Full Text] [Related]
33. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
34. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Authier FJ; Chariot P; Gherardi RK
Muscle Nerve; 2005 Sep; 32(3):247-60. PubMed ID: 15902690
[TBL] [Abstract][Full Text] [Related]
35. Critical Care in Human Immunodeficiency Virus-Infected Patients.
Akgün KM; Miller RF
Semin Respir Crit Care Med; 2016 Apr; 37(2):303-17. PubMed ID: 26974306
[TBL] [Abstract][Full Text] [Related]
36. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy.
Morris A; Creasman J; Turner J; Luce JM; Wachter RM; Huang L
Am J Respir Crit Care Med; 2002 Aug; 166(3):262-7. PubMed ID: 12153955
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.
Vincent B; Timsit JF; Auburtin M; Schortgen F; Bouadma L; Wolff M; Regnier B
Intensive Care Med; 2004 May; 30(5):859-66. PubMed ID: 14767592
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era.
Cribbs SK; Tse C; Andrews J; Shenvi N; Martin GS
Crit Care Med; 2015 Aug; 43(8):1638-45. PubMed ID: 25853590
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.
Pantanowitz L; Bohac G; Cooley TP; Aboulafia D; Dezube BJ
BJU Int; 2008 Jun; 101(12):1519-23. PubMed ID: 18384640
[TBL] [Abstract][Full Text] [Related]
40. The oncology impact of highly active antiretroviral therapy.
Schlichemeyer R; Chambers C; Gill MJ
J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
